Furthermore, in colorectal cancer organoid models, the suppression of FMRP, which regulates necroptosis through its interaction with RIPK1 mRNA, led to spontaneous cell death, suggesting that modulating FMRP could promote necroptosis and improve chemotherapy outcomes in chemoresistant cells [49]. This evidence concerns the gene RIPK1 and colorectal cancer.